These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27379831)

  • 21. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
    Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
    Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo.
    Li MY; Lv YC; Tong LJ; Peng T; Qu R; Zhang T; Sun YM; Chen Y; Wei LX; Geng MY; Duan WH; Xie H; Ding J
    Acta Pharmacol Sin; 2016 Mar; 37(3):398-407. PubMed ID: 26806300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
    Huang H; Georganaki M; Conze LL; Laviña B; van Hooren L; Vemuri K; van de Walle T; Ramachandran M; Zhang L; Pontén F; Bergqvist M; Smits A; Betsholtz C; Dejana E; Magnusson PU; He L; Lugano R; Dimberg A
    Neuro Oncol; 2022 Mar; 24(3):398-411. PubMed ID: 34347079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P2X7 receptor as predictor gene for glioma radiosensitivity and median survival.
    Gehring MP; Kipper F; Nicoletti NF; Sperotto ND; Zanin R; Tamajusuku AS; Flores DG; Meurer L; Roesler R; Filho AB; Lenz G; Campos MM; Morrone FB
    Int J Biochem Cell Biol; 2015 Nov; 68():92-100. PubMed ID: 26358881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme.
    Dai S; Wang X; Li X; Cao Y
    Biochem Biophys Res Commun; 2015 Nov; 467(2):204-10. PubMed ID: 26449464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
    Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
    Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Silencing of TGFβRII Can Inhibit Glioblastoma Cell Growth.
    Ordoni Aval F; Askarian Amiri S; Azadmehr A; Oladnabi M; Saadat P; Ebrahimi H; Baradaran B; Mansoori B; Pourabdolhossein F; Torabian P; Hajiahmadi M
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2681-2686. PubMed ID: 30256570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
    Yao XH; Ping YF; Chen JH; Chen DL; Xu CP; Zheng J; Wang JM; Bian XW
    J Neurooncol; 2008 Jan; 86(1):47-53. PubMed ID: 17611713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecularly targeted therapies for recurrent glioblastoma: current and future targets.
    Lau D; Magill ST; Aghi MK
    Neurosurg Focus; 2014 Dec; 37(6):E15. PubMed ID: 25434384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
    Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR
    Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of functional neuronal receptor latrophilin 1 in human acute myeloid leukaemia cells.
    Sumbayev VV; Gonçalves Silva I; Blackburn J; Gibbs BF; Yasinska IM; Garrett MD; Tonevitsky AG; Ushkaryov YA
    Oncotarget; 2016 Jul; 7(29):45575-45583. PubMed ID: 27322212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma.
    Liu T; Ma W; Xu H; Huang M; Zhang D; He Z; Zhang L; Brem S; O'Rourke DM; Gong Y; Mou Y; Zhang Z; Fan Y
    Nat Commun; 2018 Aug; 9(1):3439. PubMed ID: 30150753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.
    Danhier F; Messaoudi K; Lemaire L; Benoit JP; Lagarce F
    Int J Pharm; 2015 Mar; 481(1-2):154-61. PubMed ID: 25644286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNAi-mediated silencing of leptin gene expression increases cell death in C6 glioblastoma cells.
    Brown R; Morash B; Ur E; Wilkinson M
    Brain Res Mol Brain Res; 2005 Oct; 139(2):357-60. PubMed ID: 15964097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma.
    Zhang X; Wang S; Nan Y; Fan J; Chen W; Luan J; Wang Y; Liang Y; Li S; Tian W; Ju D
    Appl Microbiol Biotechnol; 2018 Aug; 102(15):6503-6513. PubMed ID: 29754163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
    Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
    Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma.
    Okuda T; Tasaki T; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A; Fujita M
    Anticancer Res; 2017 Jul; 37(7):3871-3876. PubMed ID: 28668888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.